Samsung is Testing Galaxy Watch Biometrics to Combat GLP-1 Muscle Loss
Samsung and Massachusetts General Hospital are investigating if wearable body composition data can prevent lean muscle wasting in patients using Ozempic and Wegovy.
Samsung and Massachusetts General Hospital are investigating if wearable body composition data can prevent lean muscle wasting in patients using Ozempic and Wegovy.
Investigating the rise of GLP-1 medication errors linked to asynchronous telehealth platforms and the dangers of 'one-stop shop' weight loss prescriptions.
Samsung and Massachusetts General Hospital are testing if Galaxy Watch body composition data can help patients prevent lean muscle loss during GLP-1 weight loss treatments.
Interim data from the VERVE-102 trial shows a significant drop in LDL cholesterol via base-editing, potentially replacing lifelong statin use.
Samsung and MGH are testing if Galaxy Watch biometric data can prevent lean muscle mass loss in patients using GLP-1 medications like Ozempic.
Testing the Hypershell X Ultra S exoskeleton in the Grand Canyon reveals the gap between marketing hype and the reality of endurance extension for mobility-impaired users.
Field testing the Hypershell X Ultra S exoskeleton reveals the reality of 'endurance extension' versus the dream of superhuman mobility in rugged terrain.
The Fitbit Air strips away the screen to prioritize comfort and AI-driven insights. Is Google's new health ecosystem the future of wearables?
A field test of the Hypershell X Ultra S exoskeleton reveals the gap between 'superhero' marketing and the reality of endurance assistance for hikers.
Medical historians are sounding the alarm on the loss of critical health data as legacy systems are decommissioned for modern AI-driven platforms.